Keigo Endo

Keigo Endo

Auto-generated profile, based on publicly available information

Keigo Endo

Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2006 in International Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
KEKeigo Endo
Keigo Endo
NONoboru Oriuchi
Noboru Oriuchi
THTetsuya Higuchi
Tetsuya Higuchi
YIYasuhiko Iida
Yasuhiko Iida
HHHirofumi Hanaoka
Hirofumi Hanaoka
KKKeiko Koyama
Keiko Koyama

1 December 2004
Verified
Journal Article
Closed access
WOWataru Okumura
Wataru Okumura
TITsutomu Iwasaki
Tsutomu Iwasaki
TTTakuji Toyama
Takuji Toyama
Tatsuya IsoTatsuya Iso
Tatsuya Iso
MAMasashi Arai
Masashi Arai
MKMasahiko Kurabayashi
Masahiko Kurabayashi

15 February 2002
Verified
Journal Article
Closed access
HKHiroyuki Kato
Hiroyuki Kato
HKHiroyuki Kuwano
Hiroyuki Kuwano
MNMasanobu Nakajima
Masanobu Nakajima
TMTatsuya Miyazaki
Tatsuya Miyazaki
MYMinako Yoshikawa
Minako Yoshikawa
KEKeigo Endo
Keigo Endo

2 November 2010 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
YTYoshito Tsushima
Yoshito Tsushima
ATAyako Taketomi-Takahashi
Ayako Taketomi-Takahashi
HTHiroyuki Takei
Hiroyuki Takei
HOHidenori Otake
Hidenori Otake
KEKeigo Endo
Keigo Endo
Computed tomography (CT) is the largest source of medical radiation exposure to the general population, and is considered a potential source of increased cancer risk. The aim of this study was to assess the current situation of CT use in Japan, and to investigate variations in radiation exposure in CT studies among institutions and scanners. Data-sheets were sent to all 126 hospitals and randomly selected 14 (15%) of 94 clinics in Gunma prefecture which had CT scanner(s). Data for patients undergoing CT during a single month (June 2008) were obtained, along with CT scan protocols for each institution surveyed. Age and sex specific patterns of CT examination, the variation in radiation exposure from CT examinations, and factors which were responsible for the variation in radiation exposure were determined. An estimated 235.4 patients per 1,000 population undergo CT examinations each year, and 50% of the patients were scanned in two or more anatomical locations in one CT session. There was a large variation in effective dose among hospitals surveyed, particularly in lower abdominal CT (range, 2.6-19.0 mSv). CT examinations of the chest and upper abdomen contributed to approximately 73.2% of the collective dose from all CT examinations. It was estimated that in Japan, approximately 29.9 million patients undergo CT annually, and the estimated annual collective effective dose in Japan was 277.4 *103 Sv person. The annual effective dose per capita for Japan was estimated to be 2.20 mSv. There was a very large variation in radiation exposure from CT among institutions surveyed. CT examinations of the chest and upper abdomen were the predominant contributors to the collective dose.

1 January 1992 in International Journal of Oncology
Verified
Journal Article
Closed access
PDF file
BIBishnuhari
Bishnuhari
BPBishnuhari Paudyal
Bishnuhari Paudyal
PPPramila Paudyal
Pramila Paudyal
NONoboru Oriuchi
Noboru Oriuchi
YTYoshito Tsushima
Yoshito Tsushima
KEKeigo Endo
Keigo Endo
Hepatocellular carcinoma (HCC) has variable 18F-fluoro-2-deoxy-D-glucose (18F-FDG) uptake and the relationship between 18F-FDG uptake with the expression of glucose transporters (Gluts) and hexokinase II (HK-II) has not been extensively examined. Present study explored the role of 18F-FDG positron emission tomography (PET) as a clinical significance and the association with Gluts and HK-II in patients with HCC. Whole body 18F-FDG PET, immunohistochemistry and western blot analysis of Glut-1 to Glut-5 and HK-II were performed in 31 patients (24 male and 7 female, range 48-75 years) with HCC. Significant correlation was found between 18F-FDG uptake and overall expression of Glut-2 (ρ=0.55, p=0.002) and HK-II (ρ=0.37, p=0.04). Expression of HK-II was correlated with Glut-2 (ρ=0.57, p=0.0009) but not with other Gluts, which indicated that Glut-2 is a major glucose transporter. The prognosis of patients with SUV ≥2 and positive Glut-2 were significantly worse than that with SUV <2 and negative Glut-2 (p=0.005 and p=0.03), respectively. Multivariate analysis showed that SUV and lymph node metastasis were independent prognostic factors. The present study indicated that combined evaluation of 18F-FDG uptake and expression of Glut-2 might have an important role for management of patients with HCC.

5 October 2005 in BMC Neurology
Verified
Journal Article
Open access
PDF file
YTYoshito Tsushima
Yoshito Tsushima
ATAyako Taketomi-Takahashi
Ayako Taketomi-Takahashi
KEKeigo Endo
Keigo Endo
Background: To determine the prevalence of abnormal findings on brain magnetic resonance (MR) examinations in adult participants of brain docking in order to assess its usefulness. Methods: We analyzed screening brain MR examinations for 1113 adults (age, 52.6+/-8.5 years; range, 22–84; 761 male and 352 female) performed during 6-year period from April 1998 to March 2004. All participants voluntarily sought a brain MR examination at their own expense. All subjects were studied using the same 1.0-T MR scanner, on axial T1-weighted spin echo (SE) images, proton-density-weighted and T2-weighted fast SE images, and intracranial MR angiography (MRA). All abnormal findings were classified into three basic categories: (1) findings with no referral necessary; (2) findings not requiring further evaluation, but which needed to be reported to the referring physician; (3) findings requiring further evaluation. Results: Participants with abnormal MR findings requiring further evaluation accounted for 1.3 %, but five of seven suspected intracranial aneurysms were not confirmed by other imaging modalities (false positive). No malignant tumors or other life-threatening pathology was detected, and only three participants (0.27 %) with abnormalities underwent surgical treatment. No participant groups were identified from our data as being high risk for MR abnormal findings requiring further evaluation. Conclusion: Brain-docking participants had a variety of abnormalities on brain MR examinations, but only a small percentage of these findings required further evaluation. The usefulness of the brain docking with MRI and MRA has yet to be proven, and at this time we cannot approve this screening procedure.